Mark David Novara, EVP and Chief Commercial Officer at Tandem Diabetes Care ($TNDM), sold shares once on the open market in the last year, totaling $45.62, with the most recent sale on March 5, 2026. He made no open market purchases during this period. His sales rank 11,606th out of 11,678 insiders by amount sold, well below the average of $8.6 million across 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | S | Common Stock | 187 | $23.05 | 37,656.0000 | 68,325,927 | 0.49% | 0.00% |
| March 16, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 7414 | $0.00 | 22,244.0000 | 68,325,927 | 25.00% | 0.01% |
| March 16, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 7414 | $0.00 | 43,383.0000 | 68,325,927 | 20.61% | 0.01% |
| March 16, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 5540 | $21.59 | 37,843.0000 | 68,325,927 | 12.77% | 0.01% |
| March 5, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | S | Common Stock | 2 | $22.81 | 35,969.0000 | 68,325,927 | 0.01% | 0.00% |
| Feb. 17, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 77 | $0.00 | 36,033.0000 | 68,325,927 | 0.21% | 0.00% |
| Feb. 17, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 77 | $0.00 | 380.0000 | 68,325,927 | 16.85% | 0.00% |
| Feb. 17, 2026 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 62 | $18.95 | 35,971.0000 | 68,325,927 | 0.17% | 0.00% |
| Dec. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 7415 | $0.00 | 29,658.0000 | 67,802,359 | 20.00% | 0.01% |
| Dec. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 3843 | $22.11 | 35,956.0000 | 67,802,359 | 9.66% | 0.01% |
| Dec. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 7415 | $0.00 | 39,799.0000 | 67,802,359 | 22.90% | 0.01% |
| Nov. 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 76 | $0.00 | 32,424.0000 | 67,802,359 | 0.23% | 0.00% |
| Nov. 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 76 | $0.00 | 457.0000 | 67,802,359 | 14.26% | 0.00% |
| Nov. 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 40 | $18.61 | 32,384.0000 | 67,802,359 | 0.12% | 0.00% |
| Sept. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 7415 | $0.00 | 37,073.0000 | 66,473,272 | 16.67% | 0.01% |
| Sept. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 7415 | $0.00 | 36,214.0000 | 66,473,272 | 25.75% | 0.01% |
| Sept. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 3866 | $12.09 | 32,348.0000 | 66,473,272 | 10.68% | 0.01% |
| Aug. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 76 | $0.00 | 28,839.0000 | 66,473,272 | 0.26% | 0.00% |
| Aug. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 40 | $10.82 | 28,799.0000 | 66,473,272 | 0.14% | 0.00% |
| Aug. 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 76 | $0.00 | 533.0000 | 66,473,272 | 12.48% | 0.00% |
| June 16, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 7414 | $0.00 | 32,609.0000 | 66,473,272 | 29.43% | 0.01% |
| June 16, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 3846 | $20.76 | 28,763.0000 | 66,473,272 | 11.79% | 0.01% |
| June 16, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 7414 | $0.00 | 44,488.0000 | 66,473,272 | 14.28% | 0.01% |
| May 30, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | A | Restricted Stock Unit | 31488 | $0.00 | 31,488.0000 | 66,473,272 | 9999.99% | 0.05% |
| May 30, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | A | Performance Stock Unit | 31486 | $0.00 | 31,486.0000 | 66,473,272 | 9999.99% | 0.05% |
| May 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 304 | $0.00 | 609.0000 | 66,473,272 | 33.30% | 0.00% |
| May 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 113 | $22.70 | 25,195.0000 | 66,473,272 | 0.45% | 0.00% |
| May 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 304 | $0.00 | 25,308.0000 | 66,473,272 | 1.22% | 0.00% |
| May 15, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | A | Common Stock | 870 | $19.30 | 25,004.0000 | 66,473,272 | 3.60% | 0.00% |
| March 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 7415 | $0.00 | 51,902.0000 | 66,473,272 | 12.50% | 0.01% |
| March 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 7415 | $0.00 | 26,873.0000 | 66,473,272 | 38.11% | 0.01% |
| March 17, 2025 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 2739 | $19.17 | 24,134.0000 | 66,473,272 | 10.19% | 0.00% |
| Dec. 16, 2024 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Common Stock | 29658 | $0.00 | 30,190.0000 | 0 | 5574.81% | 0.00% |
| Dec. 16, 2024 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | M | Restricted Stock Unit | 29658 | $0.00 | 59,317.0000 | 0 | 33.33% | 0.00% |
| Dec. 16, 2024 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | F | Common Stock | 10732 | $32.66 | 19,458.0000 | 0 | 35.55% | 0.00% |
| Nov. 15, 2024 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | P | Common Stock | 532 | $23.24 | 532.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | A | Performance Stock Unit | 913 | $0.00 | 913.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | A | Restricted Stock Unit | 913 | $0.00 | 913.0000 | 0 | 9999.99% | 0.00% |
| Dec. 15, 2023 | TANDEM DIABETES CARE INC | $TNDM | Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER | A | Restricted Stock Unit | 88975 | $0.00 | 88,975.0000 | 0 | 9999.99% | 0.00% |